Novartis plans to invest $23 billion over the next five years to expand its manufacturing and research in the U.S. The investment will cover more than...
Elstar Therapeutics Competitors or Alternatives
Elstar Therapeutics's top competitors include Perthera, NexImmune and Aura.
Elstar Therapeutics VS Perthera
Perthera is Elstar Therapeutics's #1 rival. Perthera was founded in 2012 in McLean, Virginia. Like Elstar Therapeutics, Perthera also operates in the Health Care Equipment & Services space. Perthera generates $3.3M more revenue than Elstar Therapeutics.
Elstar Therapeutics VS NexImmune
NexImmune is one of Elstar Therapeutics's top competitors. NexImmune is headquartered in Gaithersburg, Maryland, and was founded in 2011. Like Elstar Therapeutics, NexImmune also works within the Health Care Equipment & Services sector. NexImmune generates NaN% the revenue of Elstar Therapeutics.
Elstar Therapeutics VS Aura
Aura is seen as one of Elstar Therapeutics's top competitors. Aura was founded in 2009, and its headquarters is in Boston, Massachusetts. Like Elstar Therapeutics, Aura also works within the Health Care Equipment & Services sector. Aura has 12 fewer employees than Elstar Therapeutics.
Looking for similar companies to Elstar Therapeutics?
Similar Companies
Health Care Services companies in Cambridge
See 323 companies
Companies in Cambridge with revenue in $100K-5.0M rangeSee 4,155 companies
Health Care Equipment & Services companies in CambridgeSee 867 companies
Health Care Services companies in MassachusettsSee 4,221 companies
Health Care Services companies in Greater BostonSee 4,273 companies
Companies in Cambridge with employees in 25-100 rangeSee 6,594 companies
Health Care Equipment & Services companies in MassachusettsSee 8,578 companies
Health Care Equipment & Services companies in Greater BostonSee 8,587 companies
Companies in Massachusetts with revenue in $100K-5.0M rangeSee 23,189 companies
Trending News for Elstar Therapeutics and Elstar Therapeutics's Competitors
At Gilead, putting people first is central to all we do. That's why we're proud to be recognized as a responsible company by patient advocacy groups re...
Bristol Myers Squibb, announced that the US Food and Drug Administration (FDA) approved Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first─line tre...
Novartis plans to build seven new facilities in the U.S., touting the creation of up to 1,000 new jobs at the company. The new facilities will include ...
Novartis announced today that it plans to invest $23 billion over five years to expand its U.S.-based infrastructure. The company said its investment a...
Novartis plans to make San Diego the center of its West Coast research hub....
A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences may need to issue compulsory...
Newest qualitative research report on the Cancer Cell Market 2025, published by Coherent Market Insights, offers in-depth insights into regional and gl...
The Global cGAS STING Pathway Market is estimated to be valued at USD 0.71 Billion in 2024 and is expected to reach USD 3.41 Billion by 2031, growing a...
Frequently Asked Questions about Elstar Therapeutics
Who are Elstar Therapeutics's top competitors?
Elstar Therapeutics's top 3 competitors are Perthera, NexImmune, Aura.Who is similar to Elstar Therapeutics?
Perthera is the most similar to Elstar Therapeutics. NexImmune and Aura are also similar to Elstar Therapeutics.
Are Elstar Therapeutics and Perthera competitors?
Yes, Perthera is one of Elstar Therapeutics’s top competitors.